Copyright Reports & Markets. All rights reserved.

Global Toxoid Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Toxoid Vaccines Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Monovalent Tetanus Toxoid (TT)
      • 1.2.2 Diphtheria
      • 1.2.3 Tetanus
      • 1.2.4 Pertussis (DTaP)
      • 1.2.5 Diphtheria and Tetanus (DT)
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospitals And Clinics
      • 1.3.2 Government Organizations
      • 1.3.3 Research
      • 1.3.4 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GlaxoSmithKline
      • 2.1.1 Business Overview
      • 2.1.2 Toxoid Vaccines Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Merck
      • 2.2.1 Business Overview
      • 2.2.2 Toxoid Vaccines Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Merck Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Pfizer
      • 2.3.1 Business Overview
      • 2.3.2 Toxoid Vaccines Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Pfizer Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Sanofi Pasteur
      • 2.4.1 Business Overview
      • 2.4.2 Toxoid Vaccines Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 AstraZeneca
      • 2.5.1 Business Overview
      • 2.5.2 Toxoid Vaccines Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 AstraZeneca Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Bharat Biotech
      • 2.6.1 Business Overview
      • 2.6.2 Toxoid Vaccines Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Bharat Biotech Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Shenzhen Kangtai Biological Products
      • 2.7.1 Business Overview
      • 2.7.2 Toxoid Vaccines Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Valeant Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Toxoid Vaccines Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Valeant Pharmaceuticals Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Emergent Biosolutions
      • 2.9.1 Business Overview
      • 2.9.2 Toxoid Vaccines Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Astellas Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Toxoid Vaccines Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Astellas Pharma Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Panacea Biotec
      • 2.11.1 Business Overview
      • 2.11.2 Toxoid Vaccines Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Panacea Biotec Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Toxoid Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Toxoid Vaccines Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Toxoid Vaccines Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Toxoid Vaccines Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Toxoid Vaccines Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Toxoid Vaccines Market Analysis by Regions

    • 4.1 Global Toxoid Vaccines Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Toxoid Vaccines Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Toxoid Vaccines Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 4.3 Europe Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 4.5 South America Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Toxoid Vaccines Sales and Growth Rate (2014-2019)

    5 North America Toxoid Vaccines by Country

    • 5.1 North America Toxoid Vaccines Sales, Revenue and Market Share by Country
      • 5.1.1 North America Toxoid Vaccines Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 5.3 Canada Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Toxoid Vaccines Sales and Growth Rate (2014-2019)

    6 Europe Toxoid Vaccines by Country

    • 6.1 Europe Toxoid Vaccines Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Toxoid Vaccines Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 6.3 UK Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 6.4 France Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 6.5 Russia Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 6.6 Italy Toxoid Vaccines Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Toxoid Vaccines by Country

    • 7.1 Asia-Pacific Toxoid Vaccines Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Toxoid Vaccines Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
    • 7.2 China Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 7.3 Japan Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 7.4 Korea Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 7.5 India Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Toxoid Vaccines Sales and Growth Rate (2014-2019)

    8 South America Toxoid Vaccines by Country

    • 8.1 South America Toxoid Vaccines Sales, Revenue and Market Share by Country
      • 8.1.1 South America Toxoid Vaccines Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Toxoid Vaccines Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Toxoid Vaccines by Countries

    • 9.1 Middle East and Africa Toxoid Vaccines Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Toxoid Vaccines Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Toxoid Vaccines Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Toxoid Vaccines Sales and Growth Rate (2014-2019)

    10 Global Toxoid Vaccines Market Segment by Type

    • 10.1 Global Toxoid Vaccines Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Toxoid Vaccines Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Toxoid Vaccines Revenue and Market Share by Type (2014-2019)
    • 10.2 Monovalent Tetanus Toxoid (TT) Sales Growth and Price
      • 10.2.1 Global Monovalent Tetanus Toxoid (TT) Sales Growth (2014-2019)
      • 10.2.2 Global Monovalent Tetanus Toxoid (TT) Price (2014-2019)
    • 10.3 Diphtheria Sales Growth and Price
      • 10.3.1 Global Diphtheria Sales Growth (2014-2019)
      • 10.3.2 Global Diphtheria Price (2014-2019)
    • 10.4 Tetanus Sales Growth and Price
      • 10.4.1 Global Tetanus Sales Growth (2014-2019)
      • 10.4.2 Global Tetanus Price (2014-2019)
    • 10.5 Pertussis (DTaP) Sales Growth and Price
      • 10.5.1 Global Pertussis (DTaP) Sales Growth (2014-2019)
      • 10.5.2 Global Pertussis (DTaP) Price (2014-2019)
    • 10.6 Diphtheria and Tetanus (DT) Sales Growth and Price
      • 10.6.1 Global Diphtheria and Tetanus (DT) Sales Growth (2014-2019)
      • 10.6.2 Global Diphtheria and Tetanus (DT) Price (2014-2019)

    11 Global Toxoid Vaccines Market Segment by Application

    • 11.1 Global Toxoid Vaccines Sales Market Share by Application (2014-2019)
    • 11.2 Hospitals And Clinics Sales Growth (2014-2019)
    • 11.3 Government Organizations Sales Growth (2014-2019)
    • 11.4 Research Sales Growth (2014-2019)
    • 11.5 Others Sales Growth (2014-2019)

    12 Toxoid Vaccines Market Forecast (2019-2024)

    • 12.1 Global Toxoid Vaccines Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Toxoid Vaccines Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Toxoid Vaccines Market Forecast (2019-2024)
      • 12.2.2 Europe Toxoid Vaccines Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Toxoid Vaccines Market Forecast (2019-2024)
      • 12.2.4 South America Toxoid Vaccines Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Toxoid Vaccines Market Forecast (2019-2024)
    • 12.3 Toxoid Vaccines Market Forecast by Type (2019-2024)
      • 12.3.1 Global Toxoid Vaccines Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Toxoid Vaccines Market Share Forecast by Type (2019-2024)
    • 12.4 Toxoid Vaccines Market Forecast by Application (2019-2024)
      • 12.4.1 Global Toxoid Vaccines Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Toxoid Vaccines Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
      When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.

      Scope of the Report:
      The worldwide market for Toxoid Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Toxoid Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      GlaxoSmithKline
      Merck
      Pfizer
      Sanofi Pasteur
      AstraZeneca
      Bharat Biotech
      Shenzhen Kangtai Biological Products
      Valeant Pharmaceuticals
      Emergent Biosolutions
      Astellas Pharma
      Panacea Biotec

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Monovalent Tetanus Toxoid (TT)
      Diphtheria
      Tetanus
      Pertussis (DTaP)
      Diphtheria and Tetanus (DT)

      Market Segment by Applications, can be divided into
      Hospitals And Clinics
      Government Organizations
      Research
      Others

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Toxoid Vaccines product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Toxoid Vaccines, with price, sales, revenue and global market share of Toxoid Vaccines in 2017 and 2018.
      Chapter 3, the Toxoid Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Toxoid Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Toxoid Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Toxoid Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now